WO2022096607A1 - Syringe with luer tip - Google Patents
Syringe with luer tip Download PDFInfo
- Publication number
- WO2022096607A1 WO2022096607A1 PCT/EP2021/080691 EP2021080691W WO2022096607A1 WO 2022096607 A1 WO2022096607 A1 WO 2022096607A1 EP 2021080691 W EP2021080691 W EP 2021080691W WO 2022096607 A1 WO2022096607 A1 WO 2022096607A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- luer
- syringe
- over cap
- assembly
- barrel
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000001746 injection moulding Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000012815 thermoplastic material Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000002872 contrast media Substances 0.000 description 5
- 229940071643 prefilled syringe Drugs 0.000 description 5
- 238000011109 contamination Methods 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 229940079593 drug Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000012633 leachable Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- -1 polytetrafluoroethylene Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002716 delivery method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004447 silicone coating Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
- A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/3293—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle hub
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
- A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
- A61M5/347—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub rotatable, e.g. bayonet or screw
Definitions
- the present invention relates to a novel syringe design that provides certain advantages compared with known syringe designs.
- the present invention relates in particular to syringes suitable for use in medical applications, such as administration of diagnostic and therapeutic pharmaceuticals, and specifically to sterile pre-filled syringes.
- the pre-filled syringe is a medication delivery method where a syringe is filled in a manufacturing facility with a medicine. This is convenient for the end user as it eliminates the need to draw up medicine into a syringe thereby improving the efficiency at which the medicine can be given, reducing contamination risk of the injection, and increasing the accuracy of dosing.
- a pre-filled syringe can be particularly suitable and some common types of pre-filled syringe for home use include those that contain medicines like insulin and epinephrine.
- X-ray and magnetic resonance (MR) contrast agents are supplied either in flexible bags, bottles or in pre-filled syringes.
- the contrast agent In the case of contrast agent supplied in a bottle or bag, the contrast agent must be moved to an automatic injector using syringes, disposable tubes, and connectors. During this process, the end user needs to manipulate the contrast agent and several materials necessary for assembly. Frequent handling and multiple uses of syringe and other materials increases the risk of bacterial contamination.
- a prefilled syringe requires no syringe filling during the assembly procedure thereby reducing the manipulations required and lowering the risk of contamination, and reducing the time needed for the procedure.
- the present invention also has advantages in that injection of the plastic can be done in the center allowing completely uniform filling of the mould. It further eliminates one component, which is the conventional sealing tip cap (2a). Removing a material in contact with the injectable fluid also simplifies extractable, leachable and stability studies.
- Figure 1 illustrates a configuration for a known medical syringe used for supply of pre-filled contrast agent.
- the syringe includes a barrel (3) in which a Plunger (5) and Plunger rod (4) are positioned to move liquid contents out of the syringe.
- the tip cap (2a) which includes a silicone coating or a polytetrafluoroethylene (PTFE, Teflon® typically) laminate to avoid sticking, covers the Luer and acts to contain the contents of the pre-filled syringe prior to use and the over cap (2) acts to avoid dislocation of the tip cap (2a) during transport and storage.
- PTFE polytetrafluoroethylene
- Luers are part of the standardized Luer fitting system used in virtually all small-scale fluid fittings in order to make leak-free connections between two parts and are common in medical and laboratory instruments.
- a Luer fitting comprises a maletaper fitting and its mating female part.
- Syringes are one of the most common instruments using the Luer fitting system wherein the male Luer connection fits to the female needle which either screws into it or fits tightly on top.
- the present invention provides a syringe tip assembly comprising a Luer wherein the end of the Luer distal to the syringe includes a Luer tip (1 ) that forms a fluid-tight seal and is formed continuously and from the same material as the Luer.
- the present invention provides a syringe comprising:
- a plunger assembly that comprises a plunger rod (4) and a plunger (5) wherein the plunger rod (4) moveably fits within the barrel (3), and wherein when the plunger (5) is inside the barrel (3) it forms a fluid-tight seal together with the walls of the barrel (3).
- the present invention provides a method to manufacture a syringe comprising the following sequential steps:
- FIG. 2 An embodiment of a syringe of the present invention is shown in Figure 2 comprising a barrel (3), plunger (5) and plunger rod (4) (latter features sometimes referred to as gasket and gasket rod (4)).
- the syringe tip assembly of the present invention is at the end of the barrel (3) including the Luer.
- An over cap (2) is shown positioned as if it has just been removed from around the Luer. The act of unscrewing the over cap (2) from the Luer where they have been heat sealed together breaks the Luer tip (1 ) away from the Luer and allows the contents of the syringe to be accessed.
- the plunger (5) is not a separate component but is part of the plunger rod (4), which seals directly towards the syringe barrel (3) inner surface.
- FIG. 3 shows a cross-section of an embodiment of the syringe tip assembly of the present invention.
- the component shown would be manufactured as a single piece by injection moulding from a central point in the Luer tip (1 ) and includes the closed distal tip portion.
- the thinnest portion of the Luer tip (1 ) is indicated and this is where the Luer tip (1 ) fractures when the bonded over cap (2) is unscrewed or removed (in an optional version where the threads are not utilized).
- Also shown in this embodiment of the syringe tip assembly is a ring support (6) that would go around the whole circumference if the whole assembly was shown rather than a cross-section.
- This ring support (6) is designed to provide support for the over cap (2) when it’s in place over the Luer.
- the ring support (6) ensures that the over cap (2) does not dislocate, even if dropped.
- the remainder of Figure 3 shows an embodiment of an over cap (2) of the present invention that includes a central opening (2b). When this over cap (2) is fitted over the illustrated assembly the distal tip portion protrudes from the central opening (2b). In one embodiment of the manufacture of a syringe of the present invention, heat is applied to the tip portion and optionally also the central opening (2b) when the over cap (2) has been fitted such that the two components are heat sealed together.
- the components physically mate together when just the Luer tip (1 ) is heated due to the melted Luer tip (1 ) forming against the serrations shown in the central opening (2b) of the over cap (2).
- the over cap (2) of the present invention has screw-on functionality by means of compatible threads on the over cap (2) and the Luer.
- An exemplary over cap (2) could be made of polypropylene or transparent cyclo olefin polymer, preferably of the same material as the barrel (3) if needed to achieve the desired functionality.
- Figure 4 shows an embodiment of the present invention where the over cap (2) has been fitted to the syringe tip assembly and the Luer and central opening (2b) of the over cap (2) have been bonded or physically mated together by heat. The relative positioning of the over cap (2) with respect to the ring support (6) can also be seen.
- Step 5 A seguence of manufacturing steps is illustrated in Figure 5.
- the injection- moulded syringe barrel (3) including the syringe tip assembly of the invention is provided in Step 1 .
- the tip assembly is moulded with a closed Luer.
- Step 2 an over cap (2) is fitted over the syringe tip assembly so that a portion of the Luer protrudes out of a central opening (2b) in the over cap (2).
- the over cap (2) in this embodiment is screwed onto the syringe tip assembly by means of compatible threads on the components. In an alternative embodiment, the threads are not used, and the over cap (2) is merely placed in position by lowering into place.
- the over cap (2) shown has a serrated central opening (2b).
- Step 3 illustrates the result of heat sealing the Luer to the central opening (2b) of the over cap (2) to bond the components together.
- the serrations of the central opening (2b) help to ensure that the connection remains when the over cap (2) is unscrewed, thereby breaking the seal of the Luer and permitting access to the contents of the syringe.
- Figure 6 shows cross-sectional views of Steps 1 and 3 of Figure 5.
- syringe of the present invention can be manufactured more cheaply. There is one less material in contact with the product and as a result fewer extractable and leachable studies are required.
- the tip cap (2a) of the prior art requires a silicone laminate surface or silicone oiled surfaces to avoid sticking so the cost and effort to provide this component is completely avoided with the present invention. Free silicone is also undesired in injections.
- a syringe according to the present invention can be moulded with a closed Luer. This would allow for centre injection, which is normally desired, but which is impossible for a cylindrical hollow part like a known syringe.
- For the manufacture of certain known syringes either two injection points diametrically positioned are used, or one asymmetric position.
- the advantages include faster setup with one part less to control pre-injection, less waste, better hygiene (the fingers are away from the Luer), and tamper evidence by breaking the tip.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
A novel syringe arrangement is provided by the present invention. Advantages are provided both in simplification of the manufacturing process and for the end user.
Description
SYRINGE WITH LUER TIP
Technical Field of the Invention
The present invention relates to a novel syringe design that provides certain advantages compared with known syringe designs. The present invention relates in particular to syringes suitable for use in medical applications, such as administration of diagnostic and therapeutic pharmaceuticals, and specifically to sterile pre-filled syringes.
Description of Related Art
The pre-filled syringe is a medication delivery method where a syringe is filled in a manufacturing facility with a medicine. This is convenient for the end user as it eliminates the need to draw up medicine into a syringe thereby improving the efficiency at which the medicine can be given, reducing contamination risk of the injection, and increasing the accuracy of dosing. Where the end-user is the patient, a pre-filled syringe can be particularly suitable and some common types of pre-filled syringe for home use include those that contain medicines like insulin and epinephrine.
X-ray and magnetic resonance (MR) contrast agents are supplied either in flexible bags, bottles or in pre-filled syringes. In the case of contrast agent supplied in a bottle or bag, the contrast agent must be moved to an automatic injector using syringes, disposable tubes, and connectors. During this process, the end user needs to manipulate the contrast agent and several materials necessary for assembly. Frequent handling and multiple uses of syringe and other materials increases the risk of bacterial contamination. In contrast, a prefilled syringe requires no syringe filling during the assembly procedure thereby reducing the manipulations required and lowering the risk of contamination, and reducing the time needed for the procedure. The present invention also has advantages in that injection of the plastic can be done in the center allowing completely uniform filling of the mould. It further eliminates one component, which is the conventional sealing tip cap (2a). Removing a material in contact with the injectable fluid also simplifies extractable, leachable and stability studies.
Figure 1 illustrates a configuration for a known medical syringe used for supply
of pre-filled contrast agent. The syringe includes a barrel (3) in which a Plunger (5) and Plunger rod (4) are positioned to move liquid contents out of the syringe. The tip cap (2a), which includes a silicone coating or a polytetrafluoroethylene (PTFE, Teflon® typically) laminate to avoid sticking, covers the Luer and acts to contain the contents of the pre-filled syringe prior to use and the over cap (2) acts to avoid dislocation of the tip cap (2a) during transport and storage. Luers are part of the standardized Luer fitting system used in virtually all small-scale fluid fittings in order to make leak-free connections between two parts and are common in medical and laboratory instruments. A Luer fitting comprises a maletaper fitting and its mating female part. Syringes are one of the most common instruments using the Luer fitting system wherein the male Luer connection fits to the female needle which either screws into it or fits tightly on top.
Summary of the Invention
In one aspect the present invention provides a syringe tip assembly comprising a Luer wherein the end of the Luer distal to the syringe includes a Luer tip (1 ) that forms a fluid-tight seal and is formed continuously and from the same material as the Luer.
In another aspect the present invention provides a syringe comprising:
(i)a hollow cylindrical barrel (3) having a first end and a second end and walls therebetween defining a volume, wherein said barrel (3) comprises at said first end the syringe tip assembly as defined in any one of Claims 1 -4;
(ii)a plunger assembly that comprises a plunger rod (4) and a plunger (5) wherein the plunger rod (4) moveably fits within the barrel (3), and wherein when the plunger (5) is inside the barrel (3) it forms a fluid-tight seal together with the walls of the barrel (3).
In a further aspect the present invention provides a method to manufacture a syringe comprising the following sequential steps:
(a)injection moulding a hollow cylindrical barrel (3) comprising the syringe tip assembly defined in Claim 1 ;
(b)injection moulding an over cap (2) wherein said over cap (2) includes a
central opening (2b) and is configured to removably fit over said syringe tip assembly such that a section of the distal end of said assembly protrudes through said central opening (2b);
(c)heating the Luer tip (1 ) so that the assembly and the over cap (2) are heat sealed together.
Detailed Description of the Preferred Embodiments
To more clearly and concisely describe and point out the subject matter of the claimed invention, definitions are provided hereinbelow for specific terms used throughout the present specification and claims. Any exemplification of specific terms herein should be considered as a non-limiting example.
The terms “comprising” or “comprises” have their conventional meaning throughout this application and imply that the agent or composition must have the essential features or components listed, but that others may be present in addition. The term ‘comprising’ includes as a preferred subset “consisting essentially of” which means that the composition has the components listed without other features or components being present.
An embodiment of a syringe of the present invention is shown in Figure 2 comprising a barrel (3), plunger (5) and plunger rod (4) (latter features sometimes referred to as gasket and gasket rod (4)). The syringe tip assembly of the present invention is at the end of the barrel (3) including the Luer. An over cap (2) is shown positioned as if it has just been removed from around the Luer. The act of unscrewing the over cap (2) from the Luer where they have been heat sealed together breaks the Luer tip (1 ) away from the Luer and allows the contents of the syringe to be accessed. In one embodiment the plunger (5) is not a separate component but is part of the plunger rod (4), which seals directly towards the syringe barrel (3) inner surface.
The top drawing of Figure 3 shows a cross-section of an embodiment of the syringe tip assembly of the present invention. The component shown would be manufactured as a single piece by injection moulding from a central point in the Luer tip (1 ) and includes the closed distal tip portion. The thinnest portion of the
Luer tip (1 ) is indicated and this is where the Luer tip (1 ) fractures when the bonded over cap (2) is unscrewed or removed (in an optional version where the threads are not utilized). Also shown in this embodiment of the syringe tip assembly is a ring support (6) that would go around the whole circumference if the whole assembly was shown rather than a cross-section. This ring support (6) is designed to provide support for the over cap (2) when it’s in place over the Luer. The ring support (6) ensures that the over cap (2) does not dislocate, even if dropped. The remainder of Figure 3 shows an embodiment of an over cap (2) of the present invention that includes a central opening (2b). When this over cap (2) is fitted over the illustrated assembly the distal tip portion protrudes from the central opening (2b). In one embodiment of the manufacture of a syringe of the present invention, heat is applied to the tip portion and optionally also the central opening (2b) when the over cap (2) has been fitted such that the two components are heat sealed together. In the embodiment shown in Figure 3 the components physically mate together when just the Luer tip (1 ) is heated due to the melted Luer tip (1 ) forming against the serrations shown in the central opening (2b) of the over cap (2). In one embodiment the over cap (2) of the present invention has screw-on functionality by means of compatible threads on the over cap (2) and the Luer. An exemplary over cap (2) could be made of polypropylene or transparent cyclo olefin polymer, preferably of the same material as the barrel (3) if needed to achieve the desired functionality.
Figure 4 shows an embodiment of the present invention where the over cap (2) has been fitted to the syringe tip assembly and the Luer and central opening (2b) of the over cap (2) have been bonded or physically mated together by heat. The relative positioning of the over cap (2) with respect to the ring support (6) can also be seen.
A seguence of manufacturing steps is illustrated in Figure 5. The injection- moulded syringe barrel (3) including the syringe tip assembly of the invention is provided in Step 1 . The tip assembly is moulded with a closed Luer. In Step 2 an over cap (2) is fitted over the syringe tip assembly so that a portion of the Luer protrudes out of a central opening (2b) in the over cap (2). The over cap (2) in this embodiment is screwed onto the syringe tip assembly by means of
compatible threads on the components. In an alternative embodiment, the threads are not used, and the over cap (2) is merely placed in position by lowering into place. The over cap (2) shown has a serrated central opening (2b). Step 3 illustrates the result of heat sealing the Luer to the central opening (2b) of the over cap (2) to bond the components together. The serrations of the central opening (2b) help to ensure that the connection remains when the over cap (2) is unscrewed, thereby breaking the seal of the Luer and permitting access to the contents of the syringe.
Figure 6 shows cross-sectional views of Steps 1 and 3 of Figure 5.
There are a number of very useful advantages of the present invention.
Having one less component compared to known syringe designs means the syringe of the present invention can be manufactured more cheaply. There is one less material in contact with the product and as a result fewer extractable and leachable studies are required.
The tip cap (2a) of the prior art requires a silicone laminate surface or silicone oiled surfaces to avoid sticking so the cost and effort to provide this component is completely avoided with the present invention. Free silicone is also undesired in injections.
With the arrangement of the prior art leak-detection is impossible by visual means and it is required to do this e.g. using an X-ray machine to inspect.
A syringe according to the present invention can be moulded with a closed Luer. This would allow for centre injection, which is normally desired, but which is impossible for a cylindrical hollow part like a known syringe. For the manufacture of certain known syringes either two injection points diametrically positioned are used, or one asymmetric position.
For the end user the advantages include faster setup with one part less to control pre-injection, less waste, better hygiene (the fingers are away from the Luer), and tamper evidence by breaking the tip.
This written description uses examples to disclose the invention, including the best mode, and also to enable any person skilled in the art to practice the invention, including making and using any devices or systems and performing
any incorporated methods. The patentable scope of the invention is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal languages of the claims. All patents and patent applications mentioned in the text are hereby incorporated by reference in their entireties, as if they were individually incorporated.
Claims
(1 ) A syringe tip assembly comprising a Luer wherein the end of the Luer distal to the syringe includes a Luer tip (1 ) (1 ) that forms a fluid-tight seal and is formed continuously and from the same material as the Luer.
(2) The syringe tip assembly as defined in Claim 1 which further comprises an over cap (2) (2) that is configured to removably engage with the Luer.
(3) The syringe tip assembly as defined in Claim 2 wherein the overcap and the Luer are bonded together of physically integrated by heat deformation.
(4) The syringe tip assembly as defined in Claim 3 wherein the over cap (2) and the Luer are both made from a thermoplastic material and are bonded together of physically integrated by heat.
(5) A syringe comprising:
(i) a hollow cylindrical barrel (3) (3) having a first end and a second end and walls therebetween defining a volume, wherein said barrel (3) comprises at said first end the syringe tip assembly as defined in any one of Claims 1-4;
(ii) a plunger assembly that comprises a plunger rod (4) and a plunger (5) wherein the plunger rod (4) moveably fits within the barrel (3), and wherein when the plunger (5) is inside the barrel (3) it forms a fluid-tight seal together with the walls of the barrel (3).
(6) A method to manufacture a syringe comprising the following sequential steps:
(a) injection moulding a hollow cylindrical barrel (3) comprising the syringe tip assembly defined in Claim 1 ;
(b) injection moulding an over cap (2) wherein said over cap (2) includes a central opening (2b) and is configured to removably fit over said syringe tip assembly such that a section of the distal end of said assembly protrudes through said central opening (2b);
(c) heating the Luer tip (1 ) so that the assembly and the over cap (2) are heat sealed together.
-7-
(7) The method as defined in Claim 6 wherein step (c) also includes heating the central opening (2b).
(8) The method as defined in Claim 6 wherein the heated Luer tip (1 ) physically integrates into the edges of the central opening (2b) to allow the function of breaking the Luer tip (1 ) away from the Luer, when the over cap (2) is subsequently removed.
-8-
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2017671.5A GB202017671D0 (en) | 2020-11-09 | 2020-11-09 | Novel syringe |
GB2017671.5 | 2020-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022096607A1 true WO2022096607A1 (en) | 2022-05-12 |
Family
ID=74046375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/080691 WO2022096607A1 (en) | 2020-11-09 | 2021-11-04 | Syringe with luer tip |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202017671D0 (en) |
WO (1) | WO2022096607A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040159564A1 (en) * | 2001-01-12 | 2004-08-19 | Eakins Michael N. | Tamper evident syringe barrel |
US20090149817A1 (en) * | 2006-01-19 | 2009-06-11 | Laboratoire Aguettant | Pre-Filled Hypodermic Syringe Fitted With a Stoppering Device |
US20130079726A1 (en) * | 2009-12-16 | 2013-03-28 | Graham John Madin | Syringes |
US20150141934A1 (en) * | 2013-11-18 | 2015-05-21 | Excelsior Medical Corporation | Medicant injection device |
US20150246185A1 (en) * | 2012-09-26 | 2015-09-03 | Transcoject Gmbh | Prefilled syringe |
-
2020
- 2020-11-09 GB GBGB2017671.5A patent/GB202017671D0/en not_active Ceased
-
2021
- 2021-11-04 WO PCT/EP2021/080691 patent/WO2022096607A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040159564A1 (en) * | 2001-01-12 | 2004-08-19 | Eakins Michael N. | Tamper evident syringe barrel |
US20090149817A1 (en) * | 2006-01-19 | 2009-06-11 | Laboratoire Aguettant | Pre-Filled Hypodermic Syringe Fitted With a Stoppering Device |
US20130079726A1 (en) * | 2009-12-16 | 2013-03-28 | Graham John Madin | Syringes |
US20150246185A1 (en) * | 2012-09-26 | 2015-09-03 | Transcoject Gmbh | Prefilled syringe |
US20150141934A1 (en) * | 2013-11-18 | 2015-05-21 | Excelsior Medical Corporation | Medicant injection device |
Also Published As
Publication number | Publication date |
---|---|
GB202017671D0 (en) | 2020-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5899889A (en) | Prefilled syringe | |
US9345642B2 (en) | Vial adapter for a needle-free syringe | |
KR102401509B1 (en) | Tip cap assembly for closing an injection system | |
US7175609B1 (en) | Syringe and method of using | |
US9108031B2 (en) | Connector having a membrane, for connecting a syringe to a container or tubing | |
EP0847770B1 (en) | Prefilled syringe | |
US11964141B2 (en) | System and method for safety syringe | |
WO2004037329A1 (en) | Method of producing syringe, cap, and prefilled syringe | |
JP2015503994A (en) | Multiple dose vials and methods | |
US10512591B2 (en) | Cartridge assembly for an injection system | |
AU2013370560A1 (en) | Cartridge assembly for an injection system | |
WO2022096607A1 (en) | Syringe with luer tip | |
CN109963792B (en) | Rotary operated container closure | |
US11925793B2 (en) | Apparatus for injecting a fluid, comprising a needle assembly and a needle retention device for retaining a needle of the needle assembly when attached to the apparatus, and needle retention device | |
JP2024516256A (en) | Valve, method for manufacturing the valve, cap for a fluid container with such a valve, fluid container with such a cap, and method for manufacturing such a cap | |
JP2020146523A (en) | Medication delivery device | |
CN102028619B (en) | Can the container of accommodating different injection medicament | |
US20130261591A1 (en) | Vial device and methods | |
JP2580793Y2 (en) | Pressure-resistant holder for container and syringe | |
JPH0910281A (en) | Mouth part structure for medicine container | |
US20240017012A1 (en) | System and method for multiple site dispensing or injection | |
US20240252758A1 (en) | Injection system and method | |
EP4316550A1 (en) | Tip cap assembly for an injection system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21806227 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21806227 Country of ref document: EP Kind code of ref document: A1 |